Sorbus Biomedical is a Deep Tech company developing novel disruptive technology to improve the functional health and value of cells cultivated in the lab. We are looking for pre-seed of 900.000 Euro in Q2 2023 to revolutionize the field by launching a frugal technology which can be used in research, industry, and in healthcare. We intend to bring about a ISO-certified and CE-marked device for market launch in Scandinavia 2024.
GET INVOLVED
For conference production and speaking opportunites: